Hikal Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Partnering with Pharmaceutical, Life Sciences, Biotech & Specialty Chemicals Companies to deliver APIs, Intermediate & R&D Services.
One of their notable products is MEMANTINE HYDROCHLORIDE USP, with a corresponding US DMF Number 23567.
Remarkably, this DMF maintains an Active status since its submission on February 22, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 29, 2014, and payment made on January 21, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II